Novartis and the NHS have reached a deal for Leqvio after NICE (the healthcare agency) approved the medication.
According to company, the drug will treat more than 300,000 people at risk for a heart attack in the next three-years.
The medicine forms part of larger campaign to combat cardiovascular disease in the UK.
Currently, around 7.6 million Brits are living with circulatory and heart diseases.
Publiated at Thu, 2 Sep 2021 15:02:05 +0000